In this editor's desk, Rebekah Jordan shares her views on the achievements within pharma sustainability in 2022, its criticality in pharma investment opportunities, and what's still to be done.
Approaching the end of the year – and the final EPM issue of 2022 - is always a good time for reflection. And in terms of pharma, it’s been a year of progression.